Heat Biologics Inc: Rises as it teams up to develop coronavirus test

Scorpius Holdings

23/03/2020 12:36

** Shares of vaccine developer  HTBX.O  soar 14.9% to 69
cents premarket
    ** Company says it has entered into a collaboration with
researchers at the University of Miami to develop a COVID-19
point-of-care diagnostic test designed to deliver results on a
paper strip in under 30 minutes [https://bit.ly/2xfakyD
]
    ** HTBX is working on an experimental vaccine for the
coronavirus in collaboration with University of Miami Miller
School of Medicine  urn:newsml:reuters.com:*:nL4N2AY42U
    ** Shares soared as much as 42% on March 17 after World
Health Organization added HTBX's COVID-19 vaccine to its draft
of potential vaccine candidates for the coronavirus (http://bit.ly/2xIMBqB)
    ** Company also roped in a bipartisan government relations
firm earlier this month, to assist in securing government funds
for HTBX's vaccine program  urn:newsml:reuters.com:*:nL4N2B43NK
    ** Up to Friday's close, HTBX had gained 27.6% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))